Final Results

AI SummaryClose X

Cambridge Nutritional Sciences PLC reported revenues of £7.0 million for the year ended March 31, 2026, a decrease from £8.3 million in the prior year, attributed to challenging market conditions and internal restructuring. Despite this, the gross margin improved to 67.8% from 65.3%. The company experienced an adjusted EBITDA loss of £0.4 million, compared to a profit of £0.4 million in 2025, and a statutory loss before taxation of £4.4 million, impacted by a £3 million goodwill impairment. Cash and deposits stood at £2.6 million, down from £4.9 million. Operationally, the company implemented a new Laboratory Information Management System, improved product yields to 65%, and remains sufficiently funded for its IVDR project and future growth, while also appointing a new Global Sales Director and implementing a Customer Success Team.

Disclaimer*

UK 100

Latest directors dealings